missing translation for 'onlineSavingsMsg'
Learn More

PAPSS2 Antibody (OTI7E8), Novus Biologicals Biologicals™

Mouse Monoclonal Antibody

Brand:  Novus Biologicals NBP3-44897-100ul

 View more versions of this product

Product Code. 30306702

  • 550.00€ / 100µL

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

PAPSS2 Monoclonal antibody specifically detects PAPSS2 in Human,Mouse,Rat samples. It is validated for Immunohistochemistry
TRUSTED_SUSTAINABILITY
Specifications

Specifications

PAPSS2
Monoclonal
Unconjugated
PBS (pH 7.3) 1% BSA, 50% glycerol
Mouse
>95%
RUO
Primary
Human, Mouse, Rat
Antibody
IgG1
Immunohistochemistry
OTI7E8
Immunohistochemistry 1:150
3'-phosphoadenosine 5'-phosphosulfate synthase 2, ATP sulfurylase/adenosine 5'-phosphosulfate kinase, ATPSK2ATP sulfurylase/APS kinase 2, bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase 2, bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthethase 2, EC 2.7.1.25, PAPS synthase 2, PAPS synthetase 2, PAPSS 2, SK 2, SK2, Sulfurylase kinase 2,3-prime-phosphoadenosine 5-prime-phosphosulfate synthase 2
Human recombinant protein fragment corresponding to amino acids 1-247 of human PAPSS2(NP_004661) produced in E.coli.
100 μL
Stem Cell Markers
9060
Store at -20 degrees C. Avoid freeze/thaw cycles.
Purified
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.